Medicine

Medical research monitoring

Weekly monitoring of PubMed, clinical guidelines and meta-analyses in your specialty — structured reviews with evidence levels

Practicing physician — any specialty
Clinical resident, postgraduate — exam and publication preparation
Department head — clinical reviews and rounds
Medical professional of any specialty — who needs to stay current with evidence-based medicine

A single narrow topic (e.g., heart failure) produces 10,000+ articles per year on PubMed. Reading everything is impossible. Missing a treatment standard change is dangerous. Manual systematization — no time.

+Your articles and PDFs — added to the database alongside found ones+Clinical cases — for searching relevant studies+Current department protocols — for comparison with current guidelines+Topics and MeSH tags for monitoring

Source monitoring

Regular search across PubMed, Cochrane, OpenAlex by specified topics and MeSH tags. GistiQ visits professional society websites — ESC, AHA/ACC — and checks for guideline updates. Downloads full-text PDFs of open access articles. You can set any topics: SGLT2 inhibitors, heart failure, atrial fibrillation — as many areas as needed.

Structured analysis

Each article is analyzed by template: study design, N patients, primary endpoint, result, NNT, limitations. Separation by evidence level: RCTs and meta-analyses (level A) separately from expert opinions and case reports. Comparison of new data with what's already in the database — "does this change previous recommendations or confirm them?". Flags: a new article contradicts the current guideline → flagged separately.

Formatting

Research comparison tables in LaTeX — ready for conferences, rounds, clinical reviews. Summaries in PDF — can be printed or shared with colleagues. Everything with exact citations: DOI, authors, journal, year.

Answers to clinical questions

Answers strictly from scientific sources:

"What's new on SGLT2 in CKD patients?" — synthesis of 20+ articles with sources"Have anticoagulant recommendations for AF changed in the past year?" — specific answer with references to guidelines and studies

A cardiologist sets monitoring topics: heart failure, SGLT2 inhibitors, cardiac resynchronization. Each week receives a review: 3 new RCTs on SGLT2 (table: DAPA-CKD extension — N=4304, 39% reduction in CKD progression, NNT=19), updated ESC guideline for CHF (recommendation class for dapagliflozin changed from IIa to I), 2 meta-analyses. Each article — with structured analysis and evidence level.

What do the latest data say about the combination of sacubitril/valsartan + SGLT2 in HFrEF?

Result: synthesis from 8 articles with specific numbers, NNT, and references.